Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Scopus by Title (Ref)

1. Real-World Experience, Effectiveness, and Safety of Direct-Acting Antivirals for the Treatment of Hepatitis C in Oman: A Cross-Sectional, Multicenter Study

- Al-Naamani K.M. , et al.

2. Biopharmaceutical Production by Recombinant DNA Technology: Future Perspectives

- Parasuraman S. , et al.

3. Hepatoprotective effects of metformin in hepatitis C virus-infected adolescents with beta thalassaemia major

- Talebi A. , et al.

4. HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives

- Maffei L. , et al.

5. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment

- Alothaid H. , et al.

6. Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis

- Yang C.F. , et al.

7. The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C

- Liang P.C. , et al.

8. Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major

- Nagral A. , et al.

9. Treatment of chronic hepatitis c in thalassemia major patients

- Sajjad S.F. , et al.